| 000 | 00967 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516122535.0 | ||
| 264 | 0 | _c20130716 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2012.10.051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDasgupta, Prokar | |
| 245 | 0 | 0 |
_aOnabotulinumtoxinA in benign prostatic hyperplasia. _h[electronic resource] |
| 260 |
_bEuropean urology _cMar 2013 |
||
| 300 |
_a504-5 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLower Urinary Tract Symptoms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xdrug therapy |
| 773 | 0 |
_tEuropean urology _gvol. 63 _gno. 3 _gp. 504-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2012.10.051 _zAvailable from publisher's website |
| 999 |
_c22287295 _d22287295 |
||